December 13, 2020 3:13:14 am
India will only grant emergency use approval to a Covid-19 vaccine based on factors such as safety, immunogenicity and efficacy, said Niti Aayog Member-Health Dr. VK Paul Saturday.
“Our regulator (will make) the right decision … in fact, safety, immunogenicity and efficacy will drive the decision,” Paul said.
“These decisions will be based on science, evidence, rules, norms … We have absolutely no pressure on the regulator to (make) the decision one way or another,” he said, adding that decision-making of the regulator the process is respected.
The Comptroller General of Drugs of India is also in contact with regulatory authorities in the UK and working together on “a particular vaccine that is common to both nations,” Paul said.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay up to date with the latest headlines
For the latest news about India, download the Indian Express app.
© The Indian Express (P) Ltd